|Last Price$42.49||Day Change (%)-0.30%|
|Open Price$42.71||Day Change ($)-0.13|
|Day Range42.42–42.81||52-Week Range35.61–43.59|
As of Fri 4/24/2015 5:58:00 PM | USD
William P. Sullivan Joins Edison International and Southern California Edison Boards of Directors
S&P 500 back for another crack at trendline resistance
Merck Announces Submission of Supplemental Biologics License Application (sBLA) to U.S. FDA for KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer
Research and Markets: ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015
Research and Markets: Discrete Diodes - Global Strategic Business Report 2015
You'll be surprised at which funds are poised for a large-growth rebound.
Agilent A reported full-year results indicating respectable revenue growth and continued improvements to profitability. We've updated our model to reflect fiscal 2006 results and are maintaining our fair value estimate. Revenues in the bio-analytical division grew 9% over last year, matching our ...
Agilent's A third-quarter gross margin was well ahead of our expectations for the quarter, and the company produced another respectable performance in year-over-year sales (15%) and order (11%) growth. The gross margin finished at 55%, much higher than our assumption for the quarter and 5 ...
This report includes candid statements and observations regarding investment strategies, individual securities, and economic and market conditions; however, there is no guarantee that these statements, opinions or forecasts will prove to be correct. Equity markets are volatile and an investor may ...
The information and opinions presented herein are not meant to be taken as investment advice. We do our best to make sure the information presented in this article is factual and correct, but Zacks cannot be held responsible for any losses incurred from investment transactions made based on ...